Scientech Research LLC Guardant Health, Inc. Transaction History
Scientech Research LLC
- $485 Billion
- Q2 2024
A detailed history of Scientech Research LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 59,023 shares of GH stock, worth $1.69 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
59,023Holding current value
$1.69 Million% of portfolio
0.35%Shares
2 transactions
Others Institutions Holding GH
# of Institutions
328Shares Held
115MCall Options Held
680KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.6MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$321 Million0.01% of portfolio
-
Baillie Gifford & CO5.87MShares$168 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$129 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$128 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.92B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...